Crowdonomics
CANCERVAX

Reg CF · Common Stock · Jun 2026

OpenReached targetReg CFCommon Equity
via StartEngine · last checked Oct 9, 2026View campaign
Raised
$570.5K / $3.9M max
14% of ceiling · target hit day 63
Investors
318
$1.8K avg
Momentum
$5K/day
best $32K · 94 days left

Raised over time

Cumulative raisedInvestors
$571K$285K$0
3181590
Jun 15, 2026 · openedOct 9, 2026 · latest
Target ($20K) hit — Aug 17, 2026, day 63Deadline Jan 12, 2027 — 95 days out

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via StartEngine, last checked Oct 9, 2026; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2024–FY2025 · hover for source
$0
−$4.4M
FY2024
$0
−$9.5M
FY2025
RevenueNet income
Metric
FY2024 audited
FY2025 audited
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$4,387,678
-$9,539,137
Taxes paid
$0
$0
Balance sheet
Cash
$183,505
$198,288
Accounts receivable
$0
$219
Total assets
$299,444
$212,394
Short-term debt
$3,421,147
$5,953,127
Long-term debt
$0
$0
Total liabilities
$3,421,147
$5,953,127
Other
Headcount
6
6

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

2 amendments
  1. Aug 21, 2026
    • Deadline Sep 14, 2026 → Jan 12, 2027

    “Extending Campaign End Date 120 Days to January 12 2027”

    Form C/A on EDGAR ↗
  2. Jul 24, 2026
    No change to filed terms

    “Added disclosures regarding shares that may be issued pursuant to stock options granted on June 19 2026”

    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

Pre-money$109.4M
Price / share$2.25
Shares offered8,888

Post-money is computed as pre-money + amount raised, so it moves while the round is open — it’s shown once the round closes.

Perks

10% bonus shares · until Jun 28, 202610% bonus$1K+
12% bonus shares · until Jun 28, 202612% bonus$2.5K+
15% bonus shares · until Jun 28, 202615% bonus$5K+
18% bonus shares · until Jun 28, 202618% bonus$10K+
22% bonus shares · until Jun 28, 202622% bonus$25K+
25% bonus shares · until Jun 28, 202625% bonus$50K+
— 5% bonus shares5% bonus$1K+
— 8% bonus shares8% bonus$2.5K+
— 10% bonus shares10% bonus$5K+
— 12% bonus shares12% bonus$10K+
— 15% bonus shares15% bonus$25K+
— 18% bonus shares18% bonus$50K+
— 20% bonus shares20% bonus$100K+

Offering details

Target$19,998
Max$3,935,534
Min investment—
OpenedJun 15, 2026
DeadlineJan 12, 2027
Days active117
Days to deadline94

Links & provenance

Source: SEC EDGAR
0001905495-26-000009
Last synced Oct 9, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.